Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)

NCT02635789 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberous Sclerosis
Angiofibroma
Hypomelanotic Macule
Plaque

Interventions

DRUG: NPC-12G gel
DRUG: Placebo gel

Sponsor

Nobelpharma